| 1 |
Kholdani CA, Fares WH. Management of right heart failure in the intensive care unit[J]. Clin Chest Med, 2015, 36 (3): 511-520.
|
| 2 |
Vieillard-Baron A, Price LC, Matthay MA. Acute cor pulmonale in ARDS[J]. Intensive Care Med, 2013, 39 (10): 1836-1838.
|
| 3 |
Vieillard-Baron A, Page B, Augarde R, et al. Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate[J]. Intensive Care Med, 2001, 27 (9): 1481-1486.
|
| 4 |
丁洁，郭晓纲. 肺栓塞危险因素与预后评价的研究进展[J/CD]. 中华危重症医学杂志（电子版），2016，9(1):58-66.
|
| 5 |
Fenton KE, Parker MM. Cardiac function and dysfun-ction in sepsis[J]. Clin Chest Med, 2016, 37 (2): 289-298.
|
| 6 |
周玥，傅永平. 血浆B型利钠肽在不同左心功能肺心病患者中的临床价值探讨[J/CD]. 中华危重症医学杂志（电子版），2016，9(3):184-186.
|
| 7 |
Lhéritier G, Legras A, Caille A, et al. Prevalence and prognostic value of acute cor pulmonale and patent foramen ovale in ventilated patients with early acute respiratory distress syndrome: a multicenter study[J]. Intensive Care Med, 2013, 39 (10):1734-1742.
|
| 8 |
Vieillard-Baron A, Prin S, Chergui K, et al. Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit[J]. Am J Respir Crit Care Med, 2002, 166 (10): 1310-1319.
|
| 9 |
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of, Cardiovascular Imaging[J]. Eur Heart J Cardiovasc Imaging, 2016, 17 (4): 412.
|
| 10 |
Aloia E, Cameli M, D'Ascenzi F, et al. TAPSE: an old but useful tool in different diseases[J]. Int J Cardiol, 2016 (225): 177-183.
|
| 11 |
Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension[J]. Am J Respir Crit Care Med, 2006, 174 (9):1034-1041.
|
| 12 |
袁婷，姚尚龙，尚游. 超声在急性呼吸窘迫综合征合并急性肺源性心脏病诊断和治疗中的应用[J]. 中华危重病急救医学，2016，28(6):573-576.
|
| 13 |
张丽娜，艾宇航，刘志勇，等. 重症医学医师主导的床旁目标导向超声心动图检查在ICU应用的可行性研究[J]. 中华危重病急救医学，2012，24(12):739-741.
|
| 14 |
Repessé X, Charron C, Vieillard-Baron A. Right ve-ntricular failure in acute lung injury and acute respiratory distress syndrome[J]. Minerva Anestesiol, 2012, 78 (8): 941-948.
|
| 15 |
Krishnan S, Schmidt GA. Acute right ventricular dy-sfunction: real-time management with echocardiography[J]. Chest, 2015, 147 (3): 835-846.
|
| 16 |
National Heart, Lung, and Blood Institute Acute Respi-ratory Distress Syndrome (ARDS) Clinical Trials network, Wheeler AP, Bernard GR, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury[J]. N Engl J Med, 2006, 354 (21): 2213-2224.
|
| 17 |
Ventetuolo CE, Klinger JR. Management of acute right ventricular failure in the intensive care unit[J]. Ann Am Thorac Soc, 2014, 11 (5): 811-822.
|
| 18 |
Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome[J]. N Engl J Med, 2000, 342 (18): 1301-1308.
|
| 19 |
Hepokoski M, Owens RL, Malhotra A, et al. Mecha-nical ventilation in acute respiratory distress syndrome at ATS 2016: the search for a patient-specific strategy[J]. J Thorac Dis, 2016, 8 (Suppl 7): S550-S552.
|
| 20 |
Tiruvoipati R, Botha JA, Pilcher D, et al. Carbon dioxide clearance in critical care[J]. Anaesth Intensive Care, 2013, 41 (2): 157-162.
|
| 21 |
Hunt JL, Bronicki RA, Anas N. Role of inhaled nitric oxide in the management of severe acute respiratory distress syndrome[J]. Front Pediatr, 2016 (4): 74.
|
| 22 |
Garg A, Vignesh C, Singh VK, et al. Acute right h-eart syndrome: rescue treatment with inhaled nitric oxide[J]. Indian J Crit Care Med, 2014, 18 (1): 40-42.
|
| 23 |
McGinn K, Reichert M. A comparison of inhaled ni-tric oxide versus inhaled epoprostenol for acute pulmonary hypertension following cardiac surgery[J]. Ann Pharmacother, 2016, 50 (1): 22-26.
|
| 24 |
Searcy RJ, Morales JR, Ferreira JA, et al. The role of inhaled prostacyclin in treating acute respiratory distress syndrome[J]. Ther Adv Respir Dis, 2015, 9 (6): 302-312.
|
| 25 |
Lang IM, Gaine SP. Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension[J]. Eur Respir Rev, 2015, 24 (138): 630-641.
|
| 26 |
Borgdorff MA, Bartelds B, Dickinson MG, et al. Silde-nafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload[J]. Am J Physiol Heart Circ Physiol, 2014, 307 (3): H361-H369.
|
| 27 |
Hussain I, Mohammed SF, Forfia PR, et al. Impaired right ventricular-pulmonary arterial coupling and effect of sildenafil in heart failure with preserved ejection fraction: an ancillary analysis from the phosphodiesterase-5 inhibition to improve clinical status and exercise capacity in diastolic heart failure (RELAX) trial[J]. Circ Heart Fail, 2016, 9 (4): e002729.
|
| 28 |
Antonucci E, Fiaccadori E, Donadello K, et al. Myoc-ardial depression in sepsis: from pathogenesis to clinical manifestations and treatment[J]. J Crit Care, 2014, 29 (4): 500-511.
|
| 29 |
Mohamed A, Nasef N, Shah V, et al. Vasopressin as a rescue therapy for refractory pulmonary hypertension in neonates: case series[J]. Pediatr Crit Care Med, 2014, 15 (2): 148-154.
|
| 30 |
Belletti A, Benedetto U, Biondi-Zoccai G, et al. The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials[J]. J Crit Care, 2017 (37): 91-98.
|
| 31 |
Haglund NA, Burdorf A, Jones T, et al. Inhaled mil-rinone after left ventricular assist device implantation[J]. J Card Fail, 2015, 21 (10): 792-797.
|
| 32 |
赖志珍，孟建标，胡马洪，等. 左西孟旦对脓毒性休克患者血流动力学及心肌损伤标志物的影响[J/CD]. 中华危重症医学杂志（电子版），2016，9(3):163-168.
|
| 33 |
Pollesello P, Parissis J, Kivikko M, et al. Levosimendan meta-analyses: Is there a pattern in the effect on mortality?[J]. Int J Cardiol, 2016 (209): 77-83.
|